Evaluation of in vitro aldose reductase inhibitory potential of alkaloidal fractions of Piper nigrum, Murraya koenigii, Argemone mexicana, and Nelumbo nucifera

References

1. Patel D, Kumar R, Laloo D, Hemalatha S. Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed 2012;2:411–20.10.1016/S2221-1691(12)60067-7Search in Google Scholar

2. Patel D, Prasad S, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012;2:320–30.10.1016/S2221-1691(12)60032-XSearch in Google Scholar

3. Reddy AB, Tammali R, Mishra R, Srivastava S, Srivastava SK, Ramana KV. Aldose reductase deficiency protects sugar-induced lens opacification in rats. Chem Biol Interact 2011;191:346–50.10.1016/j.cbi.2011.02.028Search in Google Scholar

4. El-Kabbani O, Ruiz F, Darmanin C, Chung RP. Aldose reductase structures: implications for mechanism and inhibition. Cell Mol Life Sci 2004;61:750–62.10.1007/s00018-003-3403-2Search in Google Scholar

5. Kim HM, Mok S, Lee JM, Cho EJ, Choi CK, Ku J, et al. Inhibition of aldose reductase from rat lenses by methanol extracts from Korean folk plants. Nat Prod Sci 2010;16: 285–90.Search in Google Scholar

6. Akileshwari C, Muthenna P, Nastasijević B, Joksić G, Petrash JM, Reddy GB. Inhibition of aldose reductase by Gentiana lutea extracts. Exp Diabetes Res 2012;2012:147965.10.1155/2012/147965Search in Google Scholar

7. Puppal M, Ponder J, Suryanarayana P, Reddy GB, Petrash JM, LaBarbera DV. The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis. PLoS One 2012;7:31399.10.1371/journal.pone.0031399Search in Google Scholar

8. Halder N, Joshi S, Gupta SK. Lens aldose reductase inhibiting potential of some indigenous plants. J Ethnopharmacol 2003;86:113–6.10.1016/S0378-8741(03)00052-7Search in Google Scholar

9. Lee HS, Kim MK. Rat intestinal a-glucosidase and lens aldose reductase inhibitory activities of grain extracts. Food Sci Biotechnol 2001;10:172–7.Search in Google Scholar

10. Scott JA, King GL. Oxidative stress and antioxidant treatment in diabetes. Ann N Y Acad Sci 2004;1031:204–13.10.1196/annals.1331.020Search in Google Scholar PubMed

11. Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ. Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem 2009;16:734–52.10.2174/092986709787458362Search in Google Scholar PubMed

12. Juranek I, Horakova L, Rackova L, Stefek M. Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Curr Med Chem 2009;17:552–70.10.2174/092986710790416317Search in Google Scholar PubMed

13. Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pac J Clin Nutr 2008;17:558–65.Search in Google Scholar

14. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev 1998;50:21–33.Search in Google Scholar

15. Arezzo J, Klioze S, Peterson M, Lakshminarayanan M. Zopolrestat phase II neuropathy study group: efficacy and safety results of a phase II multicenter study of the aldose reductase inhibitor zopolrestat in patients with peripheral symmetrical diabetic polyneuropathy. Diabetes Care 1996;45:276A.Search in Google Scholar

16. Dongare V, Kulkarni C, Kondawar M, Magdum C, Haldavnekar V, Arvindekar A. Inhibition of aldose reductase and anti-cataract action of trans-anethole isolated from Foeniculum vulgare Mill. fruits. Food Chem 2012;132:385–90.10.1016/j.foodchem.2011.11.005Search in Google Scholar

17. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management Pharmacol Ther 2008;120:1–34.10.1016/j.pharmthera.2008.05.005Search in Google Scholar

18. Schemmel KE, Padiyara RS, D’Souza JJ. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications 2010;24:354–60.10.1016/j.jdiacomp.2009.07.005Search in Google Scholar

19. Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Shichiri M, et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 2006;29:1538–44.10.2337/dc05-2370Search in Google Scholar

20. Harlev E, Nevo E, Mirsky N, Ofir R. Antidiabetic attributes of desert and steppic plants: a review. Planta Med 2013;79: 425–36.10.1055/s-0032-1328331Search in Google Scholar

21. Patel MB, Mishra S. Isoquinoline alkaloids from Tinospora cordifolia inhibit rat lens aldose reductase. Phytother Res 2012;26:1342–7.10.1002/ptr.3721Search in Google Scholar

22. Sharma B, Salunke R, Balomajumder C, Daniel S, Roy P. Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice. J Ethnopharmacol 2010;127:457–62.10.1016/j.jep.2009.10.013Search in Google Scholar

23. Jung HA, Yoon NY, Bae HJ, Min BS, Choi JS. Inhibitory activities of the alkaloids from Coptidis rhizoma against aldose reductase. Arch Pharm Res 2008;31:1405–12.10.1007/s12272-001-2124-zSearch in Google Scholar

24. Lee HS. Rat lens aldose reductase inhibitory activities of Coptis japonica root-derived isoquinoline alkaloids. J Agric Food Chem 2002;50:7013–6.10.1021/jf020674oSearch in Google Scholar

25. Nakai N, Fujii Y, Kobashi K, Nomura K. Aldose reductase inhibitors: flavonoids, alkaloids, acetophenones, benzophenones, and spirohydantoins of chroman. Arch Biochem Biophys 1985;239:491–6.10.1016/0003-9861(85)90717-9Search in Google Scholar

26. Rajvaidhya S, Nagori BP, Singh GK, Dubey BK, Desai P, Jain S. A review on Argemone mexicana Linn. – an Indian medicinal plant. IJPSR 2012;3:2494–501.Search in Google Scholar

27. Yang ZD, Zhang X, Du J, Ma ZJ, Guo F, Li S, et al. An aporphine alkaloid from Nelumbo nucifera as an acetylcholinesterase inhibitor and the primary investigation for structure-activity correlations. Nat Prod Res 2012;26:387–92.10.1080/14786419.2010.487188Search in Google Scholar PubMed

28. Chang YC, Chang FR, Khalil AT, Hsieh PW, Wu YC. Cytotoxic benzophenanthridine and benzylisoquinoline alkaloids from Argemone mexicana. Z Naturforsch C 2003;58:521–6.10.1515/znc-2003-7-813Search in Google Scholar PubMed

29. Nayak P, Madhab.Kar D, Maharana L. Antidiabetic activity of aerial parts of Argemone Mexicana Linn. In alloxan induced hyperglycemic rats. Pharmacol Online 2011;1: 889–903.Search in Google Scholar

30. Nguyen KH, Ta TN, Pham TH, Nguyen QT, Pham HD, Mishra S, et al. Nuciferine stimulates insulin secretion from beta cells – an in vitro comparison with glibenclamide. J Ethnopharmacol 2012;142:488–95.10.1016/j.jep.2012.05.024Search in Google Scholar PubMed

31. Mani SS, Subramanian IP, Pillai SS, Muthusamy K. Evaluation of hypoglycemic activity of inorganic constituents in Nelumbo nucifera seeds on streptozotocin-induced diabetes in rats. Biol Trace Elem Res 2010;138:226–37.10.1007/s12011-010-8614-4Search in Google Scholar PubMed

32. Atal S, Agrawal RP, Vyas S, Phadnis P, Rai N. Evaluation of the effect of piperine per se on blood glucose level in alloxan-induced diabetic mice. Acta Pol Pharm 2012;69:965–9.Search in Google Scholar

33. P S, Zinjarde SS, Bhargava SY, Kumar AR. Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants. BMC Complement Altern Med 2011;20:11–15.10.1186/1472-6882-11-5Search in Google Scholar PubMed PubMed Central

34. Gupta P, Nahata A, Dixit VK. An update on Murraya koenigii spreng: a multifunctional Ayurvedic herb. Zhong Xi Yi Jie He Xue Bao 2011;9:824–33.10.3736/jcim20110803Search in Google Scholar

35. Lawal HA, Atiku MK, Khelpai DG, Wannang NN. Hypoglycaemic and hypolipidaemic effect of aqueous leaf extract of Murraya koenigii in normal and alloxan-diabetic rats. Niger J Physiol Sci 2008;23:37–40.Search in Google Scholar

36. Singh AP, Singh AJ, Singh N. Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in rats. Indian J Pharmacol 2011;43:551–6.10.4103/0253-7613.84971Search in Google Scholar PubMed PubMed Central

37. Kaur G, Jaggi AS, Singh N. Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats. J Brachial Plex Peripher Nerve Inj 2012;25:3–5.Search in Google Scholar

38. Singh K, Jaggi AS, Singh N. Exploring the ameliorative potential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice. Phytother Res 2009; 23:1565–74.10.1002/ptr.2822Search in Google Scholar PubMed

39. Takayama H, Matsuda Y, Masubuchi K, Ishida A, Kitajima M, Aimi N. Isolation, structure elucidation, and total synthesis of two new Chimonanthus alkaloids, chimonamidine and chimonanthidine. Tetrahedron 2004;60:893–900.10.1016/j.tet.2003.11.034Search in Google Scholar

40. Karasu C, Cumaoğlu A, Gürpinar AR, Kartal M, Kovacikova L, Milackova I, et al. Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts. Interdiscip Toxicol 2012;5:15–20.10.2478/v10102-012-0003-8Search in Google Scholar PubMed PubMed Central

41. Patel D, Kumar R, Kumar M, Sairam K, Hemalatha S. Evaluation of in vitro aldose reductase inhibitory potential of different fraction of Hybanthus enneaspermus Linn F. Muell. Asian Pac J Trop Biomed 2012;2:134–9.10.1016/S2221-1691(11)60207-4Search in Google Scholar

42. Hayman S, Kinoshita JH. Isolation and properties of lens aldose reductase. J Biol Chem 1965;240:877–82.10.1016/S0021-9258(17)45256-2Search in Google Scholar

43. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75.10.1016/S0021-9258(19)52451-6Search in Google Scholar

44. Chethan S, Dharmesh SM, Malleshi NG. Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols. Bioorg Med Chem 2008;23:10085–90.10.1016/j.bmc.2008.10.003Search in Google Scholar PubMed

45. Suryanarayana P, Kumar PA, Saraswat M, Petrash JM, Reddy GB. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol Vis 2004;10:148–54.Search in Google Scholar

46. Pacher P, Obrosova IG, Mabley JG, Szabó C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005;12:267–75.10.2174/0929867053363207Search in Google Scholar PubMed PubMed Central

47. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–20.10.1038/414813aSearch in Google Scholar PubMed

48. Kaneko M, Bucciarelli M, Hwang YC, Lee L, Yan SF, Schmidt AM, et al. Aldose reductase and AGE-RAGE pathway: key players in myocardial ischemic injury. Ann NY Acad Sci 2005;1043:702–9.10.1196/annals.1333.081Search in Google Scholar PubMed

49. Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003;14:S233–36.10.1097/01.ASN.0000077408.15865.06Search in Google Scholar

50. Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 2005;26:380–92.10.1210/er.2004-0028Search in Google Scholar PubMed

51. Jung HA, Kim YS, Choi JS. Quantitative HPLC analysis of two key flavonoids and inhibitory activities against aldose reductase from different parts of the Korean thistle, Cirsium maackii. Food Chem Toxicol 2009;47:2790–7.10.1016/j.fct.2009.08.014Search in Google Scholar PubMed

52. Kinoshita JH. A thirty year journey in the polyol pathway. Exp Eye Res 1991;50:567–73.10.1016/0014-4835(90)90096-DSearch in Google Scholar

53. Mukherjee PK, Saha K, Pal M, Saha BP. Effect of Nelumbo nucifera rhizome extract on blood sugar level in rats. J Ethnopharmacol 1997;58:207–13.10.1016/S0378-8741(97)00107-4Search in Google Scholar

54. Pan Y, Cai B, Wang K, Wang S, Zhou S, Yu X, et al. Neferine enhances insulin sensitivity in insulin resistant rats. J Ethnopharmacol 2009;124:98–102.10.1016/j.jep.2009.04.008Search in Google Scholar PubMed

55. Jarald E, Joshi SB, Jain DC. Diabetes and herbal medicines. IJPT 2008;7:97–106.Search in Google Scholar

56. Khan BA, Abraham A, Leelamma S. Hypoglycemic action of Murraya koenigii (curry leaf) and Brassica juncea (mustard): mechanism of action. Indian J Biochem Biophys 1995;32: 106–8.Search in Google Scholar

57. Kesari AN, Kesari S, Singh SK, Gupta RK, Watal G. Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals. J Ethnopharmacol 2007;112:305–11.10.1016/j.jep.2007.03.023Search in Google Scholar PubMed

58. Tembhurne SV, Sakarkar DM. Influence of Murraya koenigii on experimental model of diabetes and progression of neuropathic pain. Res Pharm Sci 2010;5:41–7.Search in Google Scholar

59. Jung HA, Islam MD, Kwon YS, Jin SE, Son YK, Park JJ, et al. Extraction and identification of three major aldose reductase inhibitors from Artemisia montana. Food Chem Toxicol 2011;49:76–384.10.1016/j.fct.2010.11.012Search in Google Scholar PubMed

60. Mok SY, Lee S. Identification of flavonoids and flavonoid rhamnosides from Rhododendron mucronulatum for albiflorum and their inhibitory activities against aldose reductase. Food Chem 2013;136:969–74.10.1016/j.foodchem.2012.08.091Search in Google Scholar PubMed

61. Lee YS, Kim JK, Bae YS, Won MH, Kang IJ, Lim SS. Inhibitory effect of glucodistylin from the bark of Quercus acutissima on human recombinant aldose reductase and sorbitol accumulation. Arch Pharm Res 2011;34:211–5.10.1007/s12272-011-0205-1Search in Google Scholar PubMed

62. Haraguchi H, Ohmi I, Masuda H, Tamura Y, Mizutani K, Tanaka O, et al. Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes. Experientia 1996;52:564–7.10.1007/BF01969729Search in Google Scholar PubMed

63. Morikawa T, Chaipech S, Matsuda H, Hamao M, Umeda Y, Sato H, et al. Antidiabetogenic oligostilbenoids and 3-ethyl-4-phenyl-3,4-dihydroisocoumarins from the bark of Shorea roxburghii. Bioorg Med Chem 2012; 20:832–40.10.1016/j.bmc.2011.11.067Search in Google Scholar PubMed

64. Jung HJ, Jung HA, Kang SS, Lee JH, Cho YS, Moon KH, et al. Inhibitory activity of Aralia continentalis roots on protein tyrosine phosphatase 1B and rat lens aldose reductase. Arch Pharm Res 2012;35:1771–7.10.1007/s12272-012-1009-7Search in Google Scholar PubMed

65. Lee YS, Kim SH, Jung SH, Kim JK, Pan CH, Lim SS. Aldose reductase inhibitory compounds from Glycyrrhiza uralensis. Biol Pharm Bull 2010;33:917–21.10.1248/bpb.33.917Search in Google Scholar

66. Ha TJ, Lee JH, Lee MH, Lee BW, Kwon HS, Park CH, et al. Isolation and identification of phenolic compounds from the seeds of Perilla frutescens (L.) and their inhibitory activities against α-glucosidase and aldose reductase. Food Chem 2012;135:1397–403.10.1016/j.foodchem.2012.05.104Search in Google Scholar

67. Kim JK, Lee YS, Kim SH, Bae YS, Lim SS. Inhibition of aldose reductase by phenylethanoid glycoside isolated from the seeds of Paulownia coreana. Biol Pharm Bull 2011;34:160–3.10.1248/bpb.34.160Search in Google Scholar

68. Lee I, Youn U, Kim H, Min B, Kim JS, Bae K. Biphenyl and biphenyl ether quinolizidine N-oxide alkaloids from Lagerstroemia indica L. Planta Med 2011;77:2037–41.10.1055/s-0031-1280064Search in Google Scholar

69. Liu WH, Hei ZQ, Nie H, Tang FT, Huang HQ, Li XJ, et al. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J (Engl) 2008;121:706–12.10.1097/00029330-200804020-00009Search in Google Scholar

70. El-Kabbani O, Podjarny A. Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites. Cell Mol Life Sci 2007;64:1970–8.10.1007/s00018-007-6514-3Search in Google Scholar

71. Da Settimo F, Primofiore G, Da Settimo A, La Motta C, Taliani S, Simorini F, et al. [1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives: a new class of selective aldose reductase inhibitors. J Med Chem 2001;44:4359–69.10.1021/jm0109210Search in Google Scholar

72. Urzhumtsev A, TÞte-Favier F, Mitschler A, Barbanton J, Barth P, Urzhumtseva L, et al. Specificity pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure 1997;5:601–12.10.1016/S0969-2126(97)00216-5Search in Google Scholar

73. Miyamoto S. Molecular modelling and structure based drug discovery of studies of aldose reductase inhibitors. CBIJ 2002;2:74–85.10.1273/cbij.2.74Search in Google Scholar

74. Bhandari R, Muuraya P. Curry leaf (Murraya Koenigii) or cure leaf: review of its curative properties. J Med Nutr neutraceuticals 2012;1:92–7.10.4103/2278-019X.101295Search in Google Scholar

75. Dineshkumar B, Mitra A, Mahadevappa M. Antidiabetic and hypolipidemic effects of mahanimbine (carbazole alkaloid) from murraya koenigii (rutaceae) leaves. Int J Phytomed 2012;2:22–30.Search in Google Scholar

76. El-Amin M, Virk P, Elobeid MA, Almarhoon ZM, Hassan ZK, Omer SA, et al. Anti-diabetic effect of Murraya koenigii (L) and Olea europaea (L) leaf extracts on streptozotocin induced diabetic rats. Pak J Pharm Sci 2013;26:359–65.Search in Google Scholar

77. Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine 2011;19:83–7.10.1016/j.phymed.2011.06.031Search in Google Scholar PubMed

78. Sama V, Nadipelli M, Yenumula P, Bommineni MR, Mullangi R. Effect of piperine on antihyperglycemic activity and pharmacokinetic profile of nateglinide. Arzneimittelforschung 2012;62:384–8.10.1055/s-0032-1314849Search in Google Scholar PubMed